2014 Summit Faculty interview with Louis Kuritzky, MD, about some of the benefits and risks of statin treatment, including the risk of developing diabetes.
In this 7-minute video Dr Hou, from Baylor College of Medicine, discusses his presentation in new therapeutic agents in development for treatment of IBD, from the September 26 virtual Advances in...
In this video, Antonio Anzueto, MD, talks about the findings and clinical impacts of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among...
John Harrington, MD, discusses how the pandemic has impacted medical school students and residents, treating patients with ADHD and Autism with telehealth, and the opportunities to improve the care of...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
